We have characterized the expression of ␣ 1 -adrenoceptor in epididymis from rats in different stages of sexual maturation: 40 (immature), 60 (young adult), and 120 (adult) days of age. Plasma testosterone levels were low in the immature animals but increased significantly in the 60-and 120-day-old animals. These changes were followed by a progressive increase in rat body weight and in caput and cauda epididymis relative weight. Reverse transcription polymerase chain reaction assay indicated that ␣ 1a -, ␣ 1b -, and ␣ 1d -adrenoceptor transcripts were present in both caput and cauda epididymis from adult rats. Ribonuclease protection assays further indicated that the expression of these 
INTRODUCTION
The epididymis is an organ in which sperm undergo final maturation and storage prior to ejaculation. It receives, particularly in the cauda region, autonomic innervation [1, 2] . Numerous histochemical studies have demonstrated that adrenergic and cholinergic nerve fibers course through the epididymal interstitium and are primarily associated with vascular and muscular elements [3] [4] [5] . The distribution of these nerve fibers, however, varies between the distinct epididymal regions. The cauda epididymis, with its thick mus- [3, 6] and contains greater concentrations of the adrenergic neurotransmitters adrenaline and noradrenaline compared with the caput region [7] .
The primary function of the autonomic innervation within the epididymis is to mediate neuromuscular events required for the transport of spermatozoa through the duct [8] [9] [10] . It is well known that the contractile response of cauda epididymis to nerve stimulation is primarily mediated by noradrenaline and ATP as cotransmitters released from the sympathetic nerve endings [11] . The effects of autonomic drugs on the spontaneous activity of the epididymis in the mouse in vitro [12] and in the ram in vivo [13] have been reported. Studies using both surgical and guanetidine-induced denervation have shown a decrease in the contractility and a delay in cauda luminal transit, with a significant increase in the number of spermatozoa present in cauda epididymis [14] [15] [16] [17] . The effect of the loss of innervation on the quality of sperm is, however, contradictory. Billups et al. [14] reported changes in epididymal histology, luminal fluid protein, and sperm motion parameters after removal of rat inferior mesenteric ganglion. Ricker et al. [17] also found significant decreases in the fertility of cauda epididymis sperm at 1 and 4 wk after surgical denervation. Kempinas et al. [15, 16] , however, observed that either surgical or chemical sympathectomy, induced in this case by low-level guanetidine exposure, resulted in a prolonged transit time of the sperm within epididymis, with no effects on the quality of the sperm collected from the distal cauda epididymis.
Three pharmacological ␣ 1 -adrenoceptor subtypes (␣ 1A , ␣ 1B , and ␣ 1D ), corresponding to the 3 ␣ 1 -adrenoceptor subtypes characterized by molecular cloning techniques (␣ 1a , ␣ 1b , and ␣ 1d ), have been identified recently [18] . All these receptor subtypes show high affinity to the nonspecific ␣ 1 -adrenoceptor antagonist prazosin, and they are differentially expressed in many tissues of different species [18] [19] [20] . A fourth ␣ 1 -adrenoceptor subtype designated ␣ 1L , which has not been cloned yet, exhibits lower affinity to prazosin and has been reported to be involved with contraction of human, rabbit, and dog lower urinary tract tissues [21] [22] [23] [24] . Recently, isoforms of the human and rabbit ␣ 1A -adrenoceptor generated by alternative splicing have been identified; these isoforms differ in length and sequence in the carboxyl terminal region [25] [26] [27] . The physiological significance of these isoforms remains to be clarified.
In the rat, the cauda epididymis contains postjunctional ␣ 1 -but not ␣ 2 -adrenoceptor [11, 28] , whereas in the guinea pig, the cauda epididymis contains both ␣ 1 -and ␣ 2 -adrenoceptor, which mediate contraction [29] . Several researchers have also suggested that noradrenaline may play a role in mediating epididymal epithelial cell functions, including electrolyte transport through the stimulation of ␣ 1 -and ␤-adrenoceptor [30] and protein processing [17] . Studies by Bhathal et al. [31] and Ratnasooriya and Wadsworth [32, 33] have shown that the rat epididymis is significantly af-fected by ␣ 1 -adrenoceptor blockade. In vivo treatment with different ␣ 1 -adrenoceptor antagonists induces a decrease in ejaculatory capacity associated with a reduction in the fertilization ability of the sperm, suggesting a role for the sympathetic nervous system in fertility maintenance via ␣ 1 -adrenoceptors [32, 33] . The purpose of the present work was to determine using molecular and pharmacological approaches which ␣ 1 -adrenoceptor subtypes are expressed along rat epididymis and whether changes occur in the pattern of expression of these receptors in different stages of rat sexual maturation.
MATERIALS AND METHODS

Animals and Tissue Isolation
Male Wistar rats were housed in the Animal Facility at Instituto Nacional de Farmacologia, Universidade Federal de São Paulo (UNIFESP)-Escola Paulista de Medicina. Animals were maintained on a 12L:12D lighting schedule at 20ЊC, with food and water ad libitum. The animals were killed at 40 (immature rats), 60 (young rats), and 120 (adult rats) days of age using the guidelines for the care and use of laboratory animals approved by the Research Committee from UNIFESP-Escola Paulista de Medicina. The epididymides were removed, dissected, free of fat, and sectioned into 3 segments: caput, corpus, and cauda. Caput and cauda were used in the present experiments. Total epididymis was used for the determination of the wet weight.
Measurement of Testosterone Levels
Blood from the aorta artery was collected, and the plasma levels of testosterone were measured by RIA using Coat-A-Count Total Testosterone kit (Diagnostic Products Co., Los Angeles, CA) according to manufacturer's instructions. The assay detection limit was 0.04 ng/ml, and the intraassay and interassay coefficients of variation were 2.4% and 2.8%, respectively.
RNA Isolation
Caput and cauda epididymis, brain, and heart were removed from the rats, rapidly snap frozen in liquid nitrogen, and stored at Ϫ75ЊC until use. Total RNA was extracted as previously described by Chirgwin et al. [34] . RNA samples were then quantitated, using a spectrophotometer at 260/ 280 nm and stored at Ϫ75ЊC for later use.
Reverse Transcription Polymerase Chain Reaction Assays
Reverse transcription polymerase chain reaction (RT-PCR) amplification was performed using a SUPERScript II RT kit preamplification system for first strand cDNA synthesis according to manufacturer's instructions (Gibco-BRL, Gaithersburg, MD). Reverse transcription of total RNA (5 g) using oligo(dT) [12] [13] [14] [15] [16] [17] [18] (0.5 g) was performed in a reaction volume of 20 l. Reactions in the absence of reverse transcriptase were also included for each RNA tested to check for genomic contamination. The resulting cDNA (2 l) was amplified using PCR conditions previously described [35] . Primer sequence, corresponding base sites, and sizes of the PCR products for each ␣ 1 -adrenoceptor mRNA subtype were as follows: ␣ 1a sense, GTAGCCAAGAGAGAAAGCCG (628-647) and ␣ 1a antisense, CAACCCACCACGATGCCCAG (820-839) (⌬ 212 base pairs [bp]); ␣ 1b sense, GCTCCTTCTACATCCCGCTCG (629-649) and ␣ 1b antisense, AGGGGAGCCAACATAAGATGA (908-928) (⌬ 300 bp); ␣ 1d sense, CGTGTGCTCCTTCTACCTACC (759-779) and ␣ 1d antisense, GCACAGGAGGAAGAGACCCAC (1042-1062) (⌬ 304 bp). Aliquots of the DNA samples (10 l) were loaded onto agarose gels (1.8%) containing ethidium bromide (0.5 l/ml). PCR products were visualized with fluorescent illumination and photographed. The authenticity of each target gene PCR product was confirmed by direct nucleotide sequencing performed with an ABI PRISM 377 automated sequencer (Applied Biosystems, Foster City, CA) and a BigDye Terminator sequencing kit (Applied Biosystems).
Ribonuclease Protection Assays
RNA labeling. Linearized ␣ 1 -adrenoceptor constructs were used to make antisense-strand RNA probes. RNA probes were radiolabeled with [␣ 32 P]UTP (800 Ci/mmol, 10 mCi/ml; New England Nuclear, Boston, MA) in the presence of T7 RNA polymerase with a MAXIscript in vitro transcription kit (Ambion, Austin, TX) and purified on an 8 M urea/5% polyacrylamide gel prior to use. DNA templates for antisense ␣ 1 -adrenoceptor RNA synthesis were provided by Dr. Paul C. Simpson (University of San Francisco, San Francisco, CA) and were described previously [36] . Linearized plasmid containing a 413-bp glyceraldehyde phosphate dehydrogenase (GAPDH) gene fragment in the antisense orientation under the transcriptional control of SP6 promoter was from Ambion. Sizes of the probes and protected fragments, respectively, were as follows: ␣ 1a , 408 and 315 nucleotides; ␣ 1b , 495 and 432 nucleotides; ␣ 1d , 267 and 217 nucleotides; and GAPDH, 413 and 316 nucleotides. For each ␣ 1 -adrenoceptor probe, the fraction of uridine residue available for radiolabeling was similar: ␣ 1a , 25%; ␣ 1b , 20%; ␣ 1d , 19%.
Hybridization. Hybridization of RNA probes to caput and cauda epididymis total RNA was performed by using an RPA II kit (Ambion) according to the manufacturer's instructions. Total RNA from rat brain and heart were used as positive controls for ␣ 1a (brain)-, ␣ 1d (brain)-, and ␣ 1b (heart)-adrenoceptor expression. Total RNA (90 g) and radiolabed probe (2 ϫ 10 6 cpm) were coprecipitated and then resuspended in 20 l of hybridization solution (80% deionized formamide, 100 mM sodium citrate, pH 6.4, 300 mM sodium acetate, pH 6.4, 1 mM EDTA). Probe excess was confirmed in experiments with increasing amounts of total RNA. After denaturation at 85ЊC for 10 min, samples were incubated at 58ЊC for 12-14 h. At the end of this hybridization procedure, 0.25 U/ml RNase A and 10 U/ml RNase T1 were added to digest unprotected RNA. After precipitation, pellets were resuspended in 8 l of loading buffer (95% formamide, 0.025% xylene cyanol, 0.025% bromophenol blue, 0.5 mM EDTA, 0.025% SDS), and samples were separated by electrophoresis on a denaturing 8 M urea/5% polyacrylamide gel, followed by drying and exposure to XAR-5 film (Kodak, Rochester, NY) at Ϫ70ЊC. Some control reactions included labeled probes hybridized with yeast RNA (90 g; with or without RNase digestion). The sizes of the mRNAs were determined on the gel by comparison with the 0.1-to 1.0-kilobase 32 P-RNA Century Marker Template set (Ambion). The autoradiograph was scanned using a densitometer (Shimadzu Scientific Instruments, Princeton, NJ). The steady-state level of each mRNA transcript, as estimated by the area under the curve, was normalized against that of the GAPDH mRNA in each sample. Because the ratio between the levels of ␣ 1 -adrenoceptor and GAPDH mRNA depended on the exposure time of the autoradiograph, the normalized data of the different groups were expressed as the percentage of this ratio obtained for 40-day-old rats in each experiment.
Tissue Membrane Preparation
Rat caput and cauda epididymis were minced in ice-cold buffer (25 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 , 1 mM EDTA, 1 mM PMSF, 100 g/ml bacitracin, 0.3 M sucrose) and homogenized with a homogenizer Ultra-Turrax (T25, Ika Labortechnik, Staufen, Germany). The homogenate was centrifuged (1000 ϫ g, 10 min, 4ЊC). The supernatant was saved, and the pellet was resuspended in the same buffer. After centrifugation (1000 ϫ g, 10 min, 4ЊC), the supernatant was collected in the same tube with the previous supernatant. Samples were then centrifuged (100 000 ϫ g, 1 h, 2ЊC). The final pellet was resuspended in binding buffer (25 mM TrisHCl, pH 7.4, 5 mM MgCl 2 , 1 mM EDTA, 1 mM PMSF, 100 g/ml bacitracin) using a Dounce homogenizer. The membrane preparation was aliquoted and stored at Ϫ70ЊC until use. Protein concentration was estimated with a protein reagent (Bio-Rad Laboratories, Hercules, CA) according to manufacturer's protocol.
Radioligand Binding Assay
Membrane preparations (200 g protein/ml) were incubated with binding buffer containing 1.7 nM prazosin. Competition binding data were analyzed using a weighted nonlinear least-square interactive curve-fitting program (GraphPad Prism; GraphPad Prism Software Inc., San Diego, CA). A mathematical model for 1 or 2 sites was applied. The inhibition constant (K i ) was determined from the competition curves using the Cheng and Prusoff equation [37] , using 0.19 nM for the dissociation constant as obtained by Ventura and Pennefather [28] . The potency of the antagonist was expressed as the negative logarithm of the respective K i value (pK i ).
Statistical Analysis
Data are expressed as mean Ϯ SEM. The ANOVA was followed by Bonferroni multiple range analysis, using the Instat program (GraphPad Prism Software). Differences at P Ͻ 0.05 were considered significant.
RESULTS
Plasma Testosterone Levels and Epididymis Wet Weight
Rat androgen status was monitored by measuring testosterone plasma levels. The low plasma testosterone levels observed in the immature rats (40-day-old) significantly increased with rat development (Fig. 1) . The 4-fold increase in testosterone concentration observed in 60-day-old rats was maintained in the adult rats.
The effect of sexual maturation on rat body weight and on caput and cauda epididymis wet weight is shown on Table 1 . Rat body weight significantly increased with age. Caput and cauda epididymis relative weight also increased significantly with progression of sexual maturation.
Identification of ␣ 1 -Adrenoceptor mRNA Subtypes by RT-PCR
All 3 ␣ 1 -adrenoceptor subtypes were amplified by RT-PCR with total RNA from caput and cauda epididymis from 120-day-old rats (Fig. 2) . The primers were able to amplify ␣ 1a , ␣ 1b , and ␣ 1d cDNAs, and each PCR product was of the predicted size and nucleotide sequence. No PCR products were detected when reverse transcriptase was omitted from the PCRs, demonstrating that the amplified products were from cDNA and not from genomic DNA (data not shown).
Quantification of ␣ 1 -Adrenoceptor mRNA Subtypes by RNase Protection Assay
RNase protection assays were performed on total RNA from caput and cauda epididymis from 40-, 60-, and 120-day-old rats. A single band was detected at the predicted position for each protected mRNA species (Fig. 3A) . Considering the results obtained from young and adult animals, ␣ 1a and ␣ 1d mRNA subtypes were present in cauda region, and ␣ 1a was the predominant receptor mRNA subtype in the caput region. Although ␣ 1b -adrenoceptor mRNA was abundant when total RNA from rat heart was used as a positive control (data not shown), this transcript type was present in very small amounts in both the caput and cauda regions when compared with the other 2 transcript subtypes. The expression of mRNA for GADPH did not differ between the caput and the cauda epididymis or among the different age groups in both epididymal regions. According to densitometry studies, the relative expression of ␣ 1a -adrenoceptor mRNA in the caput epididymis decreased significantly from 40 to 60 days and but not change between 60 and 120 days (Fig. 3B) . In the cauda region, ␣ 1a expression decreased from 40 to 60 days and then returned in the adult animals (120-day-old) to the same levels observed in 40-day-old rats. The expression of ␣ 1d -adrenoceptor, however, increased from 40 to 60 days. (Fig. 4) . Table 2 summarizes pK i values calculated for each antagonist.
In the caput epididymis from 40-day-old rats, the displacement curves induced by prazosin indicated a significant preference for 1-site fit (Fig. 4) . In the cauda epididymis from immature rats and in the caput and cauda epididymis from adult animals (120-day-old), the displacement curves were resolved in a 2-site fit, defining 2 ␣ 1 -adrenoceptor binding sites with high (pK iH ) and low (pK iL ) affinity (Table 2 ). When 5-methyl urapidil was used as an antagonist, all displacement curves were biphasic except in the cauda region from 40-day-old rats, which was resolved with a 1-site fit (Fig. 4 and Table 2 ). Monophasic displacement curves were obtained for BMY 7378 in the caput and cauda epididymis from immature and adult rats (Fig. 4 and Table  2 ).
Changes in ␣ 1 -adrenoceptor affinity with sexual maturation were assessed by comparing pK iH values. The potency order calculated in caput and cauda epididymis from adult rats was prazosin ϭ 5-methyl urapidil k BMY 7378. In the immature rats, the rank order depended on the portion analyzed: 5-methyl urapidil Ͼ prazosin ϭ BMY 7378 in the caput epididymis; prazosin Ͼ 5-methyl urapidil ϭ BMY 7378 in the cauda epididymis.
DISCUSSION
In the present work, the expression and changes in ␣ 1 -adrenoceptor subtypes in the epididymis with sexual maturation was characterized. RT-PCR studies indicated that all 3 ␣ 1 -adrenoceptor transcript subtypes are present in both caput and cauda epididymis from adult (120-day-old) rats. Ribonuclease protection assay, a sensitive method for RNA quantification, indicated that the level of each ␣ 1 -adrenoceptor mRNA was different depending on the epididymal region analyzed. In tissues from adult animals, ␣ 1a -adrenoceptor mRNA was predominant in the caput region and ␣ 1a -and ␣ 1d -adrenoceptor mRNA were abundant in the cauda. Transcripts for ␣ 1b -adrenoceptor were rare in both the caput and cauda regions compared with the other 2 transcripts. Heterogeneity of ␣ 1 -adrenoceptor mRNA expression, with predominance of ␣ 1a mRNA subtype, is a common finding in tissues from the rat and human male reproductive tracts, including proximal urethra, prostate, testis, and seminal vesicle [35, 36, [38] [39] [40] [41] . In human bladder, ␣ 1a -and ␣ 1d -adrenoceptor transcripts have been detected, with predominance of the ␣ 1a subtype [42] , whereas in the rat bladder all 3 transcripts were equally expressed [43] . The expression of ␣ 1d -adrenoceptor mRNA, detected in abundance in the cauda epididymis of adult rats in the present work, has been also demonstrated in human prostate [39, 44] and rat seminal vesicle [35] . Cauda epididymis is anatomically associated with the epididymal portion of the rat vas deferens, another tissue presenting an abundant expression of ␣ 1d -adrenoceptor transcripts in the male reproductive tract [36, [45] [46] [47] . Consideration should be given to the fact that ␣ 1b -adrenoceptor transcript was more readily detected by RT-PCR assay than by ribonuclease protection assay when RNA from caput and cauda epididymis was tested. Similar discrepancies have been reported in other systems and could be related to the higher sensitivity of RT-PCR for transcript detection [48, 49] .
Ribonuclease protection assays also revealed that the effect of sexual maturation on ␣ 1 -adrenoceptor mRNA subtype levels differed depending on the epididymal region analyzed. There was a reduction in ␣ 1a -adrenoceptor mRNA expression in caput epididymis from immature (40-day-old) to young adult (60-day-old) and adult (120-dayold) rats, with no change in the low level of expression for ␣ 1b and ␣ 1d transcripts. In the cauda region, ␣ 1a -adrenoceptor transcripts decreased from 40 to 60 days, returning in the adult animals to the same levels observed in the immature rats. ␣ 1d -Adrenoceptor transcripts, however, increased with age. These changes in ␣ 1 -adrenoceptor expression occurred in parallel, with no changes in the expression of the housekeeping gene GAPDH. Thus, the qualitative and quantitative changes in the expression of the different ␣ 1 -adrenoceptor transcripts suggest specific roles for these receptors in epididymal function over the course of sexual maturation.
Ventura and Pennefather [28] , using [ 3 H]prazosin-binding studies, suggested that ␣ 1 -but not ␣ 2 -adrenoceptor subtypes are present in the rat cauda epididymis. In the present work, radioligand binding studies were used to confirm that ␣ 1 -adrenoceptor at the protein level is expressed in caput and cauda epididymis during sexual maturation. The ␣ 1 -adrenoceptor antagonists prazosin, 5-methyl urapidil, and BMY 7378 displaced [ 3 H]prazosin-binding curves in both caput and cauda epididymis from 40-and 120-day-old rats, showing that ␣ 1 -adrenoceptor is present at the protein level in rat epididymis. Caput and cauda epididymis from adult animals (120-day-old) exhibited biphasic competition curves in response to [ 3 H]prazosin binding when unlabeled prazosin and 5-methyl urapidil were used as competitors. Analysis of these curves indicated the presence of 2 ␣ 1 -adrenoceptor binding sites: high affinity and low affinity. The same biphasic competition binding curves and similar high-affinity sites for prazosin and 5-methyl urapidil have been observed in membrane preparations from rabbit [50] , human [21] , and rat [41] prostate, where ␣ 1A -adrenoceptors are reported. Thus, the detection of high-affinity sites for prazosin and 5-methyl urapidil in the caput and cauda epididymis in the present study indicates that ␣ 1A -adrenoceptors are present along rat epididymis. The presence of a low-affinity site for prazosin and 5-methyl urapidil in both regions of the rat epididymis suggests the presence of different pharmacological profiles for ␣ 1A -adrenoceptor or heterogeneous ␣ 1 -adrenoceptor subtype population (␣ 1B -and/or ␣ 1D -adrenoceptor). Transcript levels for ␣ 1b -adrenoceptor were very low in both the caput and cauda regions. Furthermore, the characterization of ␣ 1B -adrenoceptor by radioligand binding cannot be clearly identified using available antagonists because chloroethylclonidine can alkylate all accessible ␣ 1A -adrenoceptor subtypes [51] . The use of BMY 7378, however, did not reveal the presence of ␣ 1D -adrenoceptor subtype in caput and cauda epididymis because pK i values were lower than those obtained for the same antagonist in ␣ 1D -adrenoceptor preparations [52] [53] [54] [55] [56] . Where ␣ 1d -adrenoceptor transcripts have been detected, steep and monophasic competition curves and low affinity to BMY 7378 have also been reported in tissues, such as rat heart, prostate, vas deferens, salivary gland, and liver [54, 57] . Comparing the pK iH values obtained in the competition binding studies in caput and cauda epididymis from adult animals, the potency order of the competitive antagonists for [ 3 H]prazosin binding was prazosin ϭ 5-methyl urapidil k BMY 7378, suggesting a predominant population of ␣ 1A -adrenoceptors. A predominant population of ␣ 1A -adrenoceptors has also been described in rat and human vas deferens [58] [59] [60] [61] [62] and prostate [63] [64] [65] and in rat seminal vesicle [35, 66, 67] .
In immature rats (40-day-old), the potency order of the ␣ 1 -adrenoceptor antagonists to displace [ 3 H]prazosin was dependent on the epididymal region analyzed. In caput epididymis, the potency order was 5-methyl urapidil Ͼ prazosin ϭ BMY 7378, and in the cauda epididymis the order was prazosin Ͼ 5-methyl urapidil ϭ BMY 7378. The pK iH values, obtained in the caput region to prazosin (8.43 Ϯ 0.16) and in the cauda region to 5-methyl urapidil (8.02 Ϯ 0.48), were still within the pK i range described previously for these antagonists in tissues and cells expressing ␣ 1A -adrenoceptors [68, 69] . Thus, caput and cauda epididymis from immature and adult rats present a predominant population of ␣ 1A -adrenoceptors. Several studies have shown that ␣ 1A -adrenoceptors mediate contraction of the epididymal portion of the rat vas deferens [70] , prostate [68] , and seminal vesicle [35] , although ␣ 1b -and ␣ 1d -adrenoceptor transcripts have been detected in these tissues. Differences in the nature of biphasic competition curves for prazosin and 5-methyl urapidil with sexual maturation will need to be explored further. Shen et al. [71] , using Western blot analysis, reported that ␣ 1 -adrenoceptor subtype proteins are expressed in most rat tissues, including vas deferens and prostate, to a varying degree and are affected differently by ontogeny. Considering the fact that different cell types are present along the epididymis, further immunological studies with selective antibodies against ␣ 1A -, ␣ 1B -, and ␣ 1D -adrenoceptor subtypes will be important for localizing and determining the relative importance of ␣ 1 -adrenoceptors in rat epididymis.
Proper development of the epididymis requires molecular signaling pathways mediated by steroid hormones and various growth factors. An important question raised by the present results concerns the physiological significance of the qualitative and quantitative changes in ␣ 1 -adrenoceptor expression in caput and cauda epididymis during the course of sexual maturation. Testosterone has been reported to increase ␣ 1 -adrenoceptor in rat tail arteries, whereas gonadectomy attenuated the total apparent number of binding sites in spontaneously hypertensive rats [72] . Philippe et al. [73] observed a Ͼ2-fold increase in the ␣ 1 -adrenoceptor in response to androgens in smooth muscle myocytes. In the male reproductive tract, the impact of androgens on ␣ 1 -adrenoceptor expression is controversial. In dog urethra, both surgical castration and estrogen administration decreased ␣ 1 -adrenoceptor and muscarinic receptors but increased ␣ 2 -adrenoceptor density [74] . In rabbit bladder base and proximal urethra, a reduction in ␣ 1 -adrenoceptor density, with no change in either ␤ 2 -adrenoceptor or muscarinic receptor density, was also demonstrated after castration [75] . No change in the absolute density of ␣ 1 -adrenoceptor [76] and a downregulation of receptor reserves for the ␣ 1a -adrenoceptor population after castration has been detected in rat prostate [77] . Changes in ␣ 1 -adrenoceptors with sexual maturation may be involved in regulating developmental events in rat epididymis. Thus, further studies will be necessary to understand the relative contribution in the rat epididymis of ␣ 1A -, ␣ 1B -, and ␣ 1D -adrenoceptor expression at the mRNA and protein levels.
The results of the present study indicated that different ␣ 1 -adrenoceptor subtypes are present in caput and cauda epididymis. Furthermore, the impact of sexual maturation on the expression of these receptor subtypes differs depending on the region of the epididymis analyzed. Elucidation of the effect of qualitative and quantitative changes in ␣ 1 -adrenoceptor expression on specific epididymal functions during the course of sexual maturation will be a major step toward understand the role of the sympathetic nervous system in male (in)fertility.
